192 related articles for article (PubMed ID: 37372960)
21. Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
Janovicz A; Majer A; Kosztelnik M; Geiszt M; Chun J; Ishii S; Tigyi GJ; Benyó Z; Ruisanchez É
Exp Biol Med (Maywood); 2023 Oct; 248(20):1887-1894. PubMed ID: 37837357
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
23. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
24. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
25. LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network.
Wang Y; Qi Z; Li Z; Bai S; Damirin A
J Cancer Res Clin Oncol; 2023 May; 149(5):2041-2055. PubMed ID: 35857125
[TBL] [Abstract][Full Text] [Related]
26. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
27. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma.
Popnikolov NK; Dalwadi BH; Thomas JD; Johannes GJ; Imagawa WT
Tumour Biol; 2012 Dec; 33(6):2237-43. PubMed ID: 22922883
[TBL] [Abstract][Full Text] [Related]
28. Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2.
Yang D; Yang W; Zhang Q; Hu Y; Bao L; Damirin A
Oncol Lett; 2013 Mar; 5(3):1048-1052. PubMed ID: 23426604
[TBL] [Abstract][Full Text] [Related]
29. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
30. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
31. Developmental changes in lysophospholipid receptor expression in rodent heart from near-term fetus to adult.
Wang F; Hou J; Han B; Nie Y; Cong X; Hu S; Chen X
Mol Biol Rep; 2012 Sep; 39(9):9075-84. PubMed ID: 22740131
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
Willier S; Butt E; Grunewald TG
Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
[TBL] [Abstract][Full Text] [Related]
33. LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs.
Mori S; Araki M; Ishii S; Hirane M; Fukushima K; Tomimatsu A; Takahashi K; Fukushima N; Tsujiuchi T
Mol Cell Biochem; 2015 Oct; 408(1-2):147-54. PubMed ID: 26116018
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
[TBL] [Abstract][Full Text] [Related]
35. Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines.
Hauck T; Kadam S; Heinz K; Garcia Peraza M; Schmid R; Kremer AE; Wolf K; Bauer A; Horch RE; Arkudas A; Kengelbach-Weigand A
Sci Rep; 2022 Apr; 12(1):5565. PubMed ID: 35365723
[TBL] [Abstract][Full Text] [Related]
36. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.
Dacheux MA; Norman DD; Tigyi GJ; Lee SC
Pharmacol Ther; 2023 May; 245():108414. PubMed ID: 37061203
[TBL] [Abstract][Full Text] [Related]
37. The Japanese lamprey (Lethenteron camtschaticum) expresses functional lysophosphatidic acid receptors.
Tamaki T; Kagawa N; Fukushima N
Biochem Biophys Res Commun; 2021 Sep; 568():1-7. PubMed ID: 34166971
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
39. Expression of factors involved in apoptosis and cell survival is correlated with enzymes synthesizing lysophosphatidic acid and its receptors in granulosa cells originating from different types of bovine ovarian follicles.
Sinderewicz E; Grycmacher K; Boruszewska D; Kowalczyk-Zięba I; Staszkiewicz J; Ślężak T; Woclawek-Potocka I
Reprod Biol Endocrinol; 2017 Sep; 15(1):72. PubMed ID: 28874163
[TBL] [Abstract][Full Text] [Related]
40. Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts.
Meng F; Yin Z; Lu F; Wang W; Zhang H
Thorac Cancer; 2024 Feb; 15(4):316-326. PubMed ID: 38124403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
